drugset / Trial / NCT03046927
Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes
Phase 2/3
Completed
48 enrolled
Benjamin U. Nwosu, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collabUniversity of Massachusetts, Worcester · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This project is designed to study the role of vitamin D supplementation on the honeymoon phase of type 1 diabetes in children who are on standardized insulin treatment. The results could lead to significant changes in the approach to the early phase of type 1 diabetes with a strong emphasis on prolonging the honeymoon phase by using vitamin D and maintaining these patients on a standardized insulin regimen. The overall goal is to reduce the long-term complications of type 1 diabetes.
Timeline
- Start
- 2017-10-19
- Primary completion
- 2021-04-12
- Completion
- 2021-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ergocalciferol | Small molecule | 50000 iu | Oral |